Flt2-13
General Information
DRACP ID DRACP04983
Peptide Name Flt2-13
Sequence SPNITVTLKKFPL
Sequence Length 13
UniProt ID Not available
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Active ACP
Activity Information
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer
Structure Information
Helicity Not available
Linear/Cyclic
Disulfide/Other Bond Native peptide
N-terminal Modification Free
C-terminal Modification Free
Other Modification None
Chiral L
Physicochemical Information
Formula C69H116N16O18
Absent amino acids ACDEGHMQRWY
Common amino acids KLPT
Mass 167199
Pl 10.81
Basic residues 2
Acidic residues 0
Hydrophobic residues 5
Net charge 2
Boman Index -450
Hydrophobicity 18.46
Aliphatic Index 112.31
Half Life
Mammalian: 1.9 hour
Yeast: >20 hour
E.coli: >10 hour
Extinction Coefficient cystines 0
Absorbance 280nm 0
Polar residues 4
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 11311231
Title A small peptide derived from Flt-1 (VEGFR-1) functions as an angiogenic inhibitor
Doi 10.1016/s0014-5793(01)02314-6
Year 2001
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available